The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country.

Feb 6 (Reuters) - Gene sequencing machine maker Illumina (ILMN.O), opens new tab forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

11 analysts have expressed a variety of opinions on Illumina ILMN over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth year in a row to the Dow Jones Best-in-Class World Index and the Dow ...

Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego ...

China bans imports of Illumina's gene sequencers right after Trump tariff action China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina , just ...